Company Filing History:
Years Active: 2021
Title: Ali Amjad: Innovator in Neurological Treatments
Introduction
Ali Amjad is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurological disorders.
Latest Patents
Ali Amjad holds a patent for his invention titled "2,2-difluorodioxolo Areceptor antagonists." This invention focuses on 2,2-difluorodioxolo compounds that act as antagonists of Areceptors. The patent outlines the potential uses of these compounds in the treatment or prevention of neurological disorders and diseases associated with Areceptors. Additionally, it includes pharmaceutical compositions that incorporate these compounds for therapeutic applications.
Career Highlights
Ali Amjad is affiliated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His work at Merck has allowed him to contribute to innovative solutions in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Gioconda V Gallo and Timothy J Henderson, who have collaborated with him on various projects within the company.
Conclusion
Ali Amjad's work in developing Areceptor antagonists represents a significant advancement in the treatment of neurological disorders. His contributions continue to impact the pharmaceutical landscape positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.